Top Banner

of 14

Sujatmoko 260110100130

Apr 06, 2018

Download

Documents

Sujatmoko Kudo
Welcome message from author
This document is posted to help you gain knowledge. Please leave a comment to let me know what you think about it! Share it to your friends and learn new things together.
Transcript
  • 8/3/2019 Sujatmoko 260110100130

    1/14

    Inhibitory activity of quinoloneagainst DNA gyrase of

    Mycobacterium tuberculosis

    Sujatmoko 260110100130

  • 8/3/2019 Sujatmoko 260110100130

    2/14

    Purpose

    To measure the inhibitory activity og quinoloneagainst Mycobacterium tuberculosisDNA gyrase

    To know the effect of variation of quinolenes

    concentration on its effect on DNA gyrasesupercoiling activity

    To know what causes quinolone resistance in M.Tuberculosis

    To understand the resistance to quinolone bymodify the GyrA and GyrB protein ins DNAgyrase

  • 8/3/2019 Sujatmoko 260110100130

    3/14

    Theory

    Multi-drug-resisten tuberculosis posesserious problem around the world, andnew pharmaceutical are needed for control

    of this disease.

    Quinolones ihibit bacterial type IItopoisomerase, DNA gyrase and

    topoisomerase IV.

    But in M. tuberculosisgenome thetopoisomerase IV wasnt identified in data

  • 8/3/2019 Sujatmoko 260110100130

    4/14

    Theory

    DNA gyrase would certainly be expectedto play an important role in drug resistance

    Single missense mutation in gyrAconferred low-level quinolone resistance,and bacteria with high level resistancehad two missence mutations gyrA

  • 8/3/2019 Sujatmoko 260110100130

    5/14

    Methods

  • 8/3/2019 Sujatmoko 260110100130

    6/14

    Methods

  • 8/3/2019 Sujatmoko 260110100130

    7/14

    Result

    Puryfication of DNA gyrase subunit protein

    The gyrA and GyrB of DNA gyrase of M.TuberculosisH37Rv were purifiedseparately:

    A factor Xa recognition site had beenintroduced into the fisuion protein and,after factor Xa disgestion, the GyrA

    and GyrB proteins migrated atappoximately 90 and 70 kDa

  • 8/3/2019 Sujatmoko 260110100130

    8/14

    Result

    GyrA and GyrBshowedsupercoiling activity

    The optimumconcentration rangfor the potassiumcation was 20-200mM and for the

    magnesiumwas>1mM

  • 8/3/2019 Sujatmoko 260110100130

    9/14

    Result

    Comparison of inhibitory activities ofantibacterial agent agains DNA gyrase

    Quinolone inhibits in concentration

    dependent mann.er

  • 8/3/2019 Sujatmoko 260110100130

    10/14

    Result

    Inhibitory avtivities ofquinolone againstaltered DNA gyrase

    Altered DNA gyrasewith Val(GTG) forALA90(GCG) ordouble substitution witAsp94(GAC)

  • 8/3/2019 Sujatmoko 260110100130

    11/14

    Discussion

    The GyrA and GyrB proteinstogetherresonstituted supercoiling activityof DNA gyrase.

    Among the quinolone tested the inhibitoryactivity of sitafloxacin was especially high.

    Reported that the level of quinoloneresistance is depends on Mycobacteriumtype.

  • 8/3/2019 Sujatmoko 260110100130

    12/14

    The resistance is related to amino acid atposition 90 (ser83 of gyrA in E.coli)

    The studies was confirmed thar DNAgyrase which have alanin at position 83,were higher resistance.

    Quinolones inhibitory activities to DNAgyrase with single change in GyrA were 28times weaker than wild type

  • 8/3/2019 Sujatmoko 260110100130

    13/14

    These result indicates that while themutatuin confferes quinolone resistance,an aditional target could also contribute to

    quinolone resistance

    The purified gyrA with substitution of va foral90 and gly for asp94 indicated that the

    addition of a second mutatuion causedeven greater resistance

  • 8/3/2019 Sujatmoko 260110100130

    14/14